Target Price | $7.38 |
Price | $1.88 |
Potential |
292.29%
register free of charge
|
Number of Estimates | 4 |
4 Analysts have issued a price target Akebia Therapeutics, Inc. 2026 .
The average Akebia Therapeutics, Inc. target price is $7.38.
This is
292.29%
register free of charge
$10.00
431.91%
register free of charge
$6.00
219.15%
register free of charge
|
|
A rating was issued by 4 analysts: 4 Analysts recommend Akebia Therapeutics, Inc. to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Akebia Therapeutics, Inc. stock has an average upside potential 2026 of
292.29%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 160.18 | 192.37 |
17.70% | 20.10% | |
Net Margin | -46.32% | -22.50% |
43.20% | 51.43% |
4 Analysts have issued a sales forecast Akebia Therapeutics, Inc. 2025 . The average Akebia Therapeutics, Inc. sales estimate is
This results in the following potential growth metrics:
4 Akebia Therapeutics, Inc. Analysts have issued a net profit forecast 2025. The average Akebia Therapeutics, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.33 | -0.19 |
17.86% | 42.42% | |
P/E | negative | |
EV/Sales | 3.30 |
4 Analysts have issued a Akebia Therapeutics, Inc. forecast for earnings per share. The average Akebia Therapeutics, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Akebia Therapeutics, Inc....
Analyst | Rating | Action | Date |
---|---|---|---|
Jefferies |
Locked
➜
Locked
|
Locked | Apr 01 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 14 2025 |
Piper Sandler |
Locked
➜
Locked
|
Locked | Mar 14 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 23 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 14 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Oct 23 2024 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Oct 10 2024 |
Analyst Rating | Date |
---|---|
Locked
Jefferies:
Locked
➜
Locked
|
Apr 01 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 14 2025 |
Locked
Piper Sandler:
Locked
➜
Locked
|
Mar 14 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 23 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 14 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Oct 23 2024 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Oct 10 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.